image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

NMC Health - Positive guidance for 2020

December 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • NMC
  • Price:
  • 2368p
The shares have shrugged off earlier wobbles after NMC’s capital markets day (CMD) reiterated earlier guidance for FY19 and introduced new guidance for FY20 for revenues of US$2,845m-US$2,915m and EBITDA of US$730m-US$760m, comparing favourably with consensus forecasts for US$730m.The c.1% EBITDA margin dip implied by FY’20 guidance reflects four new hospitals - two in Oman and two in the UAE, totalling 380 beds - entering ramp-up phase, so will have lower EBITDA contribution as occupancy rates build. They are expected to mature in 2-5 years, says broker Berenberg.FY’20 working capital and free cash flow are expected to be slightly worse than 2019 as a result of heavy capex, adding over 500 beds and 12-15 cl ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe